focus -WSS

focus

author：hotspot 2025-09-30 22:10:40 - browse：6784

CDC campus exterior -- first opinion coverage from STAT — ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? Adobe

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year. The other seven members’ terms ended in July, though they were extended through the year because they had no replacements. There is no chairperson.

Four of the seven remaining members are due to finish their terms at the end of June, a cumulative exodus of expertise that will create what followers of the ACIP’s work believe is an unprecedented level of inexperience on the committee. Historically, three or four new members have been appointed to four-year terms every July, ensuring the roster always includes a mix of seasoned and new members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA gives detailed accounting of AI

hotspot

WSS

FDA struggles to regulate food additives, sometimes for decades

STAT Summit: GSK CEO on pharma giant's new direction

Hospital price transparency does save money, advocate argues

The EU Joint Clinical Assessment needs to live up to its promise

Solve the antibiotic resistance crisis with preventive drugs

Beam Therapeutics to lay off 20% of its staff, re

leisure time

focus

hotspot

How one medical school became remarkably diverse

EU regulator recommends expanding Mounjaro approval to obesity

How to save PrEP access — and even expand it

FDA clears AI tool for detecting skin cancer

The cancer drug shortage isn’t new — and neither are the solutions

Think you might have Covid

Novavax promises a turnaround & Lilly roils the obesity market

eGenesis tests gene

Medical leaders decry Supreme Court decision on affirmative action

STAT Summit: Biotech founders on deal

entertainment

Francis Collins on trust in science and how Covid communications failed

How climate

FDA struggles to regulate food additives, sometimes for decades

FDA clears AI tool for detecting skin cancer

2023 STAT Wunderkinds: get to know the winners

STAT Summit: GSK CEO on pharma giant's new direction

Wikipedia

focus

focus

hotspot